These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 25496652

  • 1. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
    Vorselaars AD, van Moorsel CH, Zanen P, Ruven HJ, Claessen AM, van Velzen-Blad H, Grutters JC.
    Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
    Groen-Hakan F, Eurelings L, ten Berge JC, van Laar J, Ramakers CRB, Dik WA, Rothova A.
    JAMA Ophthalmol; 2017 Dec 01; 135(12):1352-1358. PubMed ID: 29121154
    [Abstract] [Full Text] [Related]

  • 3. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.
    Thi Hong Nguyen C, Kambe N, Kishimoto I, Ueda-Hayakawa I, Okamoto H.
    J Dermatol; 2017 Jul 01; 44(7):789-797. PubMed ID: 28295528
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
    Eurelings LEM, Miedema JR, Dalm VASH, van Daele PLA, van Hagen PM, van Laar JAM, Dik WA.
    PLoS One; 2019 Jul 01; 14(10):e0223897. PubMed ID: 31622413
    [Abstract] [Full Text] [Related]

  • 6. Comparative evaluation of serum markers in pulmonary sarcoidosis.
    Miyoshi S, Hamada H, Kadowaki T, Hamaguchi N, Ito R, Irifune K, Higaki J.
    Chest; 2010 Jun 01; 137(6):1391-7. PubMed ID: 20081103
    [Abstract] [Full Text] [Related]

  • 7. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
    Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Müller-Quernheim J.
    Am J Respir Crit Care Med; 1997 Nov 01; 156(5):1586-92. PubMed ID: 9372680
    [Abstract] [Full Text] [Related]

  • 8. YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
    Uysal P, Durmus S, Sozer V, Gelisgen R, Seyhan EC, Erdenen F, Simsek G, Uzun H.
    Biomolecules; 2018 Aug 28; 8(3):. PubMed ID: 30154391
    [Abstract] [Full Text] [Related]

  • 9. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
    Ina Y, Takada K, Noda M, Satou T, Hashiba H, Miyachi A, Ito S, Iijima N, Yamamoto M.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar 28; 29(3):316-21. PubMed ID: 2067152
    [Abstract] [Full Text] [Related]

  • 10. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
    Wieland CW, Vogl T, Ordelman A, Vloedgraven HG, Verwoolde LH, Rensen JM, Roth J, Boer J, Hessels J.
    Br J Dermatol; 2013 Jun 28; 168(6):1252-8. PubMed ID: 23320892
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of infliximab biosimilar Inflectra® in severe sarcoidosis.
    Schimmelpennink MC, Vorselaars ADM, van Beek FT, Crommelin HA, Deneer VHM, Keijsers RGM, Veltkamp M.
    Respir Med; 2018 May 28; 138S():S7-S13. PubMed ID: 29496351
    [Abstract] [Full Text] [Related]

  • 12. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.
    Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H.
    Chest; 2003 Jul 28; 124(1):186-95. PubMed ID: 12853522
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D.
    Roum Arch Microbiol Immunol; 2001 Jul 28; 60(3):183-201. PubMed ID: 12165973
    [Abstract] [Full Text] [Related]

  • 16. Microheterogeneity of acute-phase glycoproteins in patients with pulmonary sarcoidosis.
    Hrycaj P, Wurm K, Mennet P, Müller W.
    Eur Respir J; 1996 Feb 28; 9(2):313-8. PubMed ID: 8777970
    [Abstract] [Full Text] [Related]

  • 17. Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis.
    Kalkanis A, Kalkanis D, Drougas D, Vavougios GD, Datseris I, Judson MA, Georgiou E.
    Nucl Med Commun; 2016 Mar 28; 37(3):273-7. PubMed ID: 26544095
    [Abstract] [Full Text] [Related]

  • 18. Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis.
    Keicho N, Kitamura K, Takaku F, Yotsumoto H.
    Chest; 1990 Nov 28; 98(5):1125-9. PubMed ID: 2171882
    [Abstract] [Full Text] [Related]

  • 19. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis.
    Schimmelpennink MC, Quanjel M, Vorselaars A, Wiertz I, Veltkamp M, Van Moorsel C, Grutters JC.
    Expert Rev Respir Med; 2020 Jul 28; 14(7):749-756. PubMed ID: 32248706
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of Combined Measurement of Serum Soluble IL-2R and Angiotensin-Converting Enzyme in the Detection of Uveitis Associated with Japanese Sarcoidosis.
    Ishihara M, Meguro A, Ishido M, Takeuchi M, Shibuya E, Mizuki N.
    Clin Ophthalmol; 2020 Jul 28; 14():2311-2317. PubMed ID: 32848359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.